Publications of M. Theodoropoulou
All genres
Journal Article (80)
21.
Journal Article
73 (2), pp. 71 - 72 (2012)
A general overview on pituitary tumorigenesis. Annales d' Endocrinologie 22.
Journal Article
19 (1), pp. 13 - 27 (2012)
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells. Endocrine-Related Cancer 23.
Journal Article
22 (21), pp. 4182 - 4191 (2011)
The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system. Molecular Biology of the Cell 24.
Journal Article
165 (4), pp. 509 - 515 (2011)
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. European Journal of Endocrinology 25.
Journal Article
10 (8), pp. 1450 - 1459 (2011)
Levels of p27 Sensitize to Dual PI3K/mTOR Inhibition. Molecular Cancer Therapeutics 26.
Journal Article
94 (2), pp. 124 - 136 (2011)
Effect of SOM230 (Pasireotide) on Corticotropic Cells: Action in Dogs with Cushing's Disease. Neuroendocrinology 27.
Journal Article
326 (1-2), pp. 60 - 65 (2010)
ZAC1 target genes and pituitary tumorigenesis. Molecular and Cellular Endocrinology 28.
Journal Article
70 (14), pp. 6026 - 6035 (2010)
Loss of Function of the Tumor Suppressor DKC1 Perturbs p27 Translation Control and Contributes to Pituitary Tumorigenesis. Cancer Research 29.
Journal Article
70 (2), pp. 666 - 674 (2010)
The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells. Cancer Research 30.
Journal Article
117 (10), p. 657 - 657 (2009)
Octreotide enhances rapamycin's antiproliferative action by inhibiting rapamycin-induced IRS-1 and Akt activation. Experimental and Clinical Endocrinology & Diabetes 31.
Journal Article
117 (10), p. 656 - 656 (2009)
NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Experimental and Clinical Endocrinology & Diabetes 32.
Journal Article
117 (10), p. 656 - 656 (2009)
Activation of NOD and TLR4 innate immune receptors in tumoral pituitary cells and their effects on downstream targets. Experimental and Clinical Endocrinology & Diabetes 33.
Journal Article
117 (10), p. 657 - 657 (2009)
Expression, regulation and function of HIF-1 alpha and RSUME in murine and human pituitary tumor cells. Experimental and Clinical Endocrinology & Diabetes 34.
Journal Article
117 (10), pp. 657 - 658 (2009)
CB1 cannabinoid receptor positively regulates pro-opiomelanocortin (POMC) transcription through activation of the cAMP-response element (CRE)-binding protein (CREB). Experimental and Clinical Endocrinology & Diabetes 35.
Journal Article
125 (9), pp. 2122 - 2126 (2009)
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly. International Journal of Cancer 36.
Journal Article
203 (1), pp. 111 - 122 (2009)
NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Journal of Endocrinology 37.
Journal Article
16 (3), pp. 1017 - 1027 (2009)
Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocrine-Related Cancer 38.
Journal Article
16 (3), pp. 1029 - 1043 (2009)
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocrine-Related Cancer 39.
Journal Article
16 (2), pp. 599 - 611 (2009)
Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. Endocrine-Related Cancer 40.
Journal Article
16 (3), pp. 208 - 212 (2009)
Modulation of Growth Hormone and Prolactin Secretion in Trypanosoma cruzi-Infected Mammosomatotrophic Cells. Neuroimmunomodulation